tiprankstipranks
Natera Inc. (NTRA)
NASDAQ:NTRA
US Market
NTRA
Natera
RESEARCH TOOLSreports
Want to see NTRA full AI Analyst Report?

Natera (NTRA) Stock Forecast & Price Target

1,231 Followers
See the Price Targets and Ratings of:

NTRA Analyst Ratings

Strong Buy
18Ratings
Strong Buy
16 Buy
2 Hold
0 Sell
Based on 18 analysts giving stock ratings to
Natera
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NTRA Stock 12 Month Forecast

Average Price Target

$266.93
▲(28.09% Upside)
Based on 18 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $266.93 with a high forecast of $310.00 and a low forecast of $220.00. The average price target represents a 28.09% change from the last price of $208.40.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"133":"$133","222":"$222","311":"$311","177.5":"$177.5","266.5":"$266.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":310,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$310.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":266.93333333333334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$266.93</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":220,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$220.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[133,177.5,222,266.5,311],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,218.81,225.82461538461538,232.83923076923077,239.85384615384615,246.86846153846153,253.8830769230769,260.8976923076923,267.9123076923077,274.92692307692306,281.94153846153847,288.9561538461538,295.97076923076924,302.98538461538465,{"y":310,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,218.81,222.51179487179488,226.21358974358975,229.91538461538462,233.6171794871795,237.31897435897437,241.02076923076925,244.7225641025641,248.42435897435897,252.12615384615384,255.82794871794871,259.5297435897436,263.23153846153843,{"y":266.93333333333334,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,218.81,218.90153846153845,218.99307692307693,219.08461538461538,219.17615384615385,219.2676923076923,219.35923076923078,219.45076923076923,219.5423076923077,219.63384615384615,219.72538461538463,219.81692307692308,219.90846153846155,{"y":220,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":160.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.58,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.34,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":161.61,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.93,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234.25,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":229.09,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.1,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.17,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.21,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":207.28,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.81,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$310.00Average Price Target$266.93Lowest Price Target$220.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on NTRA
Eve Burstein
Bernstein
Bernstein
$310
Buy
48.75%
Upside
Assigned
06/25/26
Bernstein Initiates a Buy Rating on Natera (NTRA)
Craig-Hallum Analyst forecast on NTRA
William Bonello
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
06/24/26
Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Natera (NASDAQ: NTRA) and Vera Therapeutics (NASDAQ: VERA)
Barclays Analyst forecast on NTRA
Luke Sergott
Barclays
Barclays
$280→$260
Buy
24.76%
Upside
Assigned
06/24/26
Barclays Sticks to Its Buy Rating for Natera (NTRA)
Goldman Sachs Analyst forecast on NTRA
Evie Koslosky
Goldman Sachs
Goldman Sachs
$245
Hold
17.56%
Upside
Reiterated
06/24/26
Natera: Japan Signatera Opportunity Balanced by Valuation; Hold Rating Reiterated, $245 Price Target Maintained
Piper Sandler Analyst forecast on NTRA
David Westenberg
Piper Sandler
Piper Sandler
$249
Buy
19.48%
Upside
Reiterated
06/23/26
Natera (NTRA) Gets a Buy from Piper Sandler
Canaccord Genuity Analyst forecast on NTRA
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
$285
Buy
36.76%
Upside
Reiterated
06/23/26
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (NASDAQ: CGON), Natera (NASDAQ: NTRA) and Pfizer (NYSE: PFE)
BTIG Analyst forecast on NTRA
Mark Massaro
BTIG
BTIG
$270
Buy
29.56%
Upside
Reiterated
06/23/26
Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)
Leerink Partners Analyst forecast on NTRA
Puneet Souda
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
06/22/26
NCCN guidelines may be meaningful catalyst for Natera, says LeerinkNCCN guidelines may be meaningful catalyst for Natera, says Leerink
RBC Capital Analyst forecast on NTRA
Dan Leonard
RBC Capital
RBC Capital
$275
Buy
31.96%
Upside
Initiated
06/11/26
Natera resumed with an Outperform at RBC CapitalNatera resumed with an Outperform at RBC Capital
Citi Analyst forecast on NTRA
Patrick B Donnelly
Citi
Citi
$300
Buy
43.95%
Upside
Reiterated
05/28/26
Citi Remains a Buy on Natera (NTRA)
Morgan Stanley Analyst forecast on NTRA
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$250
Buy
19.96%
Upside
Reiterated
05/12/26
Morgan Stanley Remains a Buy on Natera (NTRA)
Wells Fargo Analyst forecast on NTRA
Brandon Couillard
Wells Fargo
Wells Fargo
$215→$220
Hold
5.57%
Upside
Reiterated
05/08/26
Natera price target raised to $220 from $215 at Wells FargoNatera price target raised to $220 from $215 at Wells Fargo
William Blair Analyst forecast on NTRA
Andrew Brackmann
William Blair
William Blair
―
Buy
―
Reiterated
05/08/26
Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), ImageneBio (NASDAQ: IMA) and Natera (NASDAQ: NTRA)
Robert W. Baird Analyst forecast on NTRA
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$257→$265
Buy
27.16%
Upside
Reiterated
05/08/26
Natera price target raised to $265 from $257 at BairdNatera price target raised to $265 from $257 at Baird
Evercore ISI Analyst forecast on NTRA
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$250→$270
Buy
29.56%
Upside
Reiterated
05/08/26
Natera price target raised to $270 from $250 at Evercore ISINatera price target raised to $270 from $250 at Evercore ISI
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on NTRA
Eve Burstein
Bernstein
Bernstein
$310
Buy
48.75%
Upside
Assigned
06/25/26
Bernstein Initiates a Buy Rating on Natera (NTRA)
Craig-Hallum Analyst forecast on NTRA
William Bonello
Craig-Hallum
Craig-Hallum
―
Buy
―
Reiterated
06/24/26
Analysts Offer Insights on Healthcare Companies: Verastem (NASDAQ: VSTM), Natera (NASDAQ: NTRA) and Vera Therapeutics (NASDAQ: VERA)
Barclays Analyst forecast on NTRA
Luke Sergott
Barclays
Barclays
$280→$260
Buy
24.76%
Upside
Assigned
06/24/26
Barclays Sticks to Its Buy Rating for Natera (NTRA)
Goldman Sachs Analyst forecast on NTRA
Evie Koslosky
Goldman Sachs
Goldman Sachs
$245
Hold
17.56%
Upside
Reiterated
06/24/26
Natera: Japan Signatera Opportunity Balanced by Valuation; Hold Rating Reiterated, $245 Price Target Maintained
Piper Sandler Analyst forecast on NTRA
David Westenberg
Piper Sandler
Piper Sandler
$249
Buy
19.48%
Upside
Reiterated
06/23/26
Natera (NTRA) Gets a Buy from Piper Sandler
Canaccord Genuity Analyst forecast on NTRA
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
$285
Buy
36.76%
Upside
Reiterated
06/23/26
Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (NASDAQ: CGON), Natera (NASDAQ: NTRA) and Pfizer (NYSE: PFE)
BTIG Analyst forecast on NTRA
Mark Massaro
BTIG
BTIG
$270
Buy
29.56%
Upside
Reiterated
06/23/26
Analysts Are Bullish on These Healthcare Stocks: Hinge Health, Inc. Class A (HNGE), Natera (NTRA)
Leerink Partners Analyst forecast on NTRA
Puneet Souda
Leerink Partners
Leerink Partners
―
Buy
―
Reiterated
06/22/26
NCCN guidelines may be meaningful catalyst for Natera, says LeerinkNCCN guidelines may be meaningful catalyst for Natera, says Leerink
RBC Capital Analyst forecast on NTRA
Dan Leonard
RBC Capital
RBC Capital
$275
Buy
31.96%
Upside
Initiated
06/11/26
Natera resumed with an Outperform at RBC CapitalNatera resumed with an Outperform at RBC Capital
Citi Analyst forecast on NTRA
Patrick B Donnelly
Citi
Citi
$300
Buy
43.95%
Upside
Reiterated
05/28/26
Citi Remains a Buy on Natera (NTRA)
Morgan Stanley Analyst forecast on NTRA
Kallum Titchmarsh
Morgan Stanley
Morgan Stanley
$250
Buy
19.96%
Upside
Reiterated
05/12/26
Morgan Stanley Remains a Buy on Natera (NTRA)
Wells Fargo Analyst forecast on NTRA
Brandon Couillard
Wells Fargo
Wells Fargo
$215→$220
Hold
5.57%
Upside
Reiterated
05/08/26
Natera price target raised to $220 from $215 at Wells FargoNatera price target raised to $220 from $215 at Wells Fargo
William Blair Analyst forecast on NTRA
Andrew Brackmann
William Blair
William Blair
―
Buy
―
Reiterated
05/08/26
Analysts Offer Insights on Healthcare Companies: Guardant Health (NASDAQ: GH), ImageneBio (NASDAQ: IMA) and Natera (NASDAQ: NTRA)
Robert W. Baird Analyst forecast on NTRA
Catherine Ramsey Schulte
Robert W. Baird
Robert W. Baird
$257→$265
Buy
27.16%
Upside
Reiterated
05/08/26
Natera price target raised to $265 from $257 at BairdNatera price target raised to $265 from $257 at Baird
Evercore ISI Analyst forecast on NTRA
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
$250→$270
Buy
29.56%
Upside
Reiterated
05/08/26
Natera price target raised to $270 from $250 at Evercore ISINatera price target raised to $270 from $250 at Evercore ISI
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

3 Months
Catherine Ramsey SchulteRobert W. Baird
Success Rate
28/40 ratings generated profit
70%
Average Return
+13.72%
Copying Catherine Ramsey Schulte's trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +13.72% per trade.
1 Year
Daniel BrennanTD Cowen
Success Rate
19/19 ratings generated profit
100%
Average Return
+56.99%
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +56.99% per trade.
2 Years
Daniel BrennanTD Cowen
Success Rate
19/19 ratings generated profit
100%
Average Return
+100.84%
Copying Daniel Brennan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +100.84% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NTRA Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
1
1
1
0
Buy
30
23
19
19
24
Hold
2
1
1
1
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
25
21
21
27
In the current month, NTRA has received 24 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. NTRA average Analyst price target in the past 3 months is 266.93.
Each month's total comprises the sum of three months' worth of ratings.

NTRA Financial Forecast

NTRA Earnings Forecast

Next quarter’s earnings estimate for NTRA is -$0.49 with a range of -$0.76 to -$0.30. The previous quarter’s EPS was -$0.60. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.
Next quarter’s earnings estimate for NTRA is -$0.49 with a range of -$0.76 to -$0.30. The previous quarter’s EPS was -$0.60. NTRA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Sales Forecast

Next quarter’s sales forecast for NTRA is $660.76M with a range of $647.60M to $684.31M. The previous quarter’s sales results were $696.64M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.
Next quarter’s sales forecast for NTRA is $660.76M with a range of $647.60M to $684.31M. The previous quarter’s sales results were $696.64M. NTRA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year NTRA has Performed in-line its overall industry.

NTRA Stock Forecast FAQ

What is NTRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Natera Inc.’s 12-month average price target is 266.93.
    What is NTRA’s upside potential, based on the analysts’ average price target?
    Natera Inc. has 28.09% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is NTRA a Buy, Sell or Hold?
          Natera Inc. has a consensus rating of Strong Buy which is based on 16 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Natera Inc.’s price target?
            The average price target for Natera Inc. is 266.93. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $310.00 ,the lowest forecast is $220.00. The average price target represents 28.09% Increase from the current price of $208.4.
              What do analysts say about Natera Inc.?
              Natera Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
                How can I buy shares of NTRA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.